Levobupivacaína Altan (Levobupivacaine)

Levobupivacaine blocks voltage‑gated sodium channels on neuronal membranes, preventing the initiation and propagation of action potentials. This reversible inhibition stops nerve impulse transmission, resulting in loss of sensation in the targeted region while preserving motor function at appropriate concentrations.

The specific dose and concentration are determined by the prescribing clinician based on the patient’s age, weight, procedure type, and clinical setting. Levobupivacaína Altan is supplied for use by qualified health‑care professionals who calculate the appropriate regimen for each individual case.

Safety data for levobupivacaine in pregnancy and lactation are limited. Use is generally reserved for situations where the benefit outweighs potential risk, such as obstetric analgesia under specialist supervision. Breastfeeding mothers should consult their obstetrician or anesthesiologist before exposure.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The sales team then replies with pricing, availability, shipping details (including cold‑chain if required) and import documentation.

Levobupivacaine is the S‑enantiomer of bupivacaine, offering a similar duration of action with a lower risk of cardiotoxicity and central nervous system toxicity. Both are amide‑type local anesthetics used epidurally, but levobupivacaine’s stereoselective profile makes it a preferred option when safety margins are a priority.

Levobupivacaína Altan should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations. Ensure the container is sealed tightly to maintain sterility until use.

The drug is administered by a qualified health‑care professional via the epidural route. After aseptic preparation, the solution is injected into the epidural space using a catheter or needle, allowing controlled spread of the anesthetic to achieve the desired sensory block.

Serious risks include cardiovascular toxicity such as arrhythmias, severe hypotension, and central nervous system effects like seizures or respiratory depression. Systemic toxicity can occur if the drug enters the bloodstream in excessive amounts, requiring immediate medical intervention.

Patients with known hypersensitivity to amide‑type local anesthetics, those with severe cardiac conduction disorders, or individuals with uncontrolled epilepsy should avoid levobupivacaine. It is also contraindicated in patients where epidural placement is unsafe, such as those with infection at the injection site or coagulopathy.